11月7日,在第九届中国国际进口博览会现场,镁信健康正式宣布对其InsRx.ai商保准入工作台进行焕新升级 1。此次升级推出了专为创新药商业保险准入打造的AI Workstation,旨在围绕药企准入团队的工作场景,构建包含商保规划、准入筹备、目录准入及准入后运营在内的四大核心功能模块 1。
作为首批入驻企业之一,强生创新制药已正式加入该AI平台 1。双方将依托专业数据与人工智能技术,共同探索创新药在商业保险领域的准入机制以及多元支付的新模式 1。这一合作致力于通过技术手段优化流程,从而提升患者对创新药物的可及性 1。
On November 7, during the ninth China International Import Expo in Shanghai, Magna Health officially announced a comprehensive upgrade of its InsRx.ai commercial insurance access workstation. 1 As part of this launch, Johnson & Johnson Innovative Medicine became one of the first enterprises to join the platform. 1
The newly upgraded InsRx.ai AI Workstation is specifically designed to address the needs of pharmaceutical companies seeking commercial insurance coverage for innovative drugs. 1 The platform centers on four core functional modules tailored to the workflows of market access teams: commercial insurance planning, access preparation, formulary inclusion, and post-access operations. 1 Through this collaboration, both parties aim to leverage professional data and artificial intelligence technologies to explore new pathways for commercial insurance access and diversified payment models, ultimately enhancing patient accessibility to innovative therapies. 1
评论
还没有评论,欢迎留下第一条。